#Curren$y hq pilot talk trilogy download
Download a Word document with a sample message to patients.
![curren$y hq pilot talk trilogy curren$y hq pilot talk trilogy](http://bendticket.boldtypetickets.com/imager/b/square/46926532/35bc/SEPTEMBER_25TH_DOMINO_ROOM.jpg)
![curren$y hq pilot talk trilogy curren$y hq pilot talk trilogy](http://www.urban75.org/blog/images/comacchio-ferrera-italy-13.jpg)
Consider mechanisms to identify patients who use a recalled Philips CPAP, BPAP, or mechanical ventilator device.The AASM advises sleep centers and sleep medicine professionals to take the following steps to inform patients about the recall: The AASM advises that patients contact their medical provider as soon as possible to discuss whether to continue or discontinue treatment. The ultimate judgment regarding any specific care must be made by the treating clinician and the patient, taking into consideration the individual circumstances of the patient, available treatment options, and resources. This decision should be made in concert between the patient and their medical provider. However, in the case that this is not an option, or another device is unavailable, then it is the AASM viewpoint that clinical factors such as comorbidities, severity of symptoms, risks associated with PAP discontinuation, and safety-sensitive roles should inform the decision to continue or discontinue therapy. The AASM suggests that the medical provider prescribe for their patient a PAP device that is not affected by the recall. Using alternative treatments for sleep apnea.Continuing to use an affected device, if a patient’s health care provider determines that the benefits outweigh the risks identified in the recall notification.Using another similar device that is not part of the recall.For patients using BPAP and CPAP devices, Philips advises that they talk to a health care provider to decide on a suitable treatment for medical conditions, which may include: Philips now advises that patients using recalled BPAP and CPAP devices should consult with their physician on a suitable treatment plan.
#Curren$y hq pilot talk trilogy update
UPDATE 11/16/21: Philips updated its guidance to align with FDA’s recommendations in connection with the recall. Call Philips at 87 for additional help and support. Additional information, including responses to frequently asked questions, will be made available by the AASM as soon as possible. This guidance document does not constitute legal advice and is not meant to substitute for the clinical or medical judgment of our clinicians or members. Members should consider discussing these options with their risk management team or counsel. The AASM is providing the following information to help sleep centers and sleep medicine professionals understand their options. Philips may contact some patients via phone and ask for their physician’s contact information, and then Philips will contact the physician directly so that the prescription can be sent to the contact information below: Philips will ask these patients to contact their physician and request a script be sent to Philips Respironics.
![curren$y hq pilot talk trilogy curren$y hq pilot talk trilogy](https://t2.genius.com/unsafe/600x600/https://images.genius.com/acd500966062f3aed392a16808ff0086.640x640x1.jpg)
In its “ Sleep and respiratory care bulletin #7,” posted in August 2022, Philips reports that many patients have registered to receive their remediated CPAP or BiPAP device, but the process to receive the replacement device is unable to take place as they no longer have a DME to confirm the prescription and therapy settings. Submitting PAP Device Prescriptions (August 2022 Update) Young Investigators Research Forum (YIRF).
![curren$y hq pilot talk trilogy curren$y hq pilot talk trilogy](https://i.ytimg.com/vi/nlBlGUTRtrM/maxresdefault.jpg)